PDB ID | 1H4R | CHAIN | A |
---|---|---|---|
Protein name | MERLIN | ||
PDB | 1H4R | ||
The number of similar proteins | 12 | ||
The number of binding states | 5 | ||
The number of binding partners | 4 |
Unicolor (beige)
The number of binding partners
Group
Only interaction residues |
|
||||||||||
|
Residue | AA | Source | dbSNP | Clinical Significance |
Allele Frequency (> 0.0001) |
Disease name | |
---|---|---|---|---|---|---|---|
20_LYS | TER |
ClinVar chr22:30000045 |
rs2064715459
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
29_MET | LEU |
8.3kJPN chr22:30000072 |
-
|
- | 0.0001 | - | |
33_MET | VAL |
8.3kJPN chr22:30000084 |
-
|
- | 0.0001 | - | |
37_CYS | TER |
ClinVar chr22:30000098 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
38_GLU | TER |
ClinVar chr22:30000099 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
40_LYS | TER |
ClinVar chr22:30032743 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
41_TRP | TER |
ClinVar chr22:30032747 |
rs1555986860
|
Pathogenic | - | not provided|Neurofibromatosis, type 2 [MedGen:C3661900|MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
57_ARG | TER |
ClinVar chr22:30032794 |
rs121434259
|
Pathogenic | - | Meningioma|not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome [Human Phenotype Ontology:HP:0002858,Human Phenotype Ontology:HP:0006754,MONDO:MONDO:0016642,MedGen:C0025286,Orphanet:2495|MedGen:C3661900|MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
60_TRP | TER |
ClinVar chr22:30032805 |
rs780872661
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
60_TRP | TER |
ClinVar chr22:30032804 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
65_GLN | TER |
ClinVar chr22:30032818 |
rs2065661533
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
115_GLN | TER |
ClinVar chr22:30035181 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
121_GLN | TER |
ClinVar chr22:30035199 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
123_LYS | TER |
ClinVar chr22:30038194 |
-
|
Likely pathogenic | - | not provided [MedGen:C3661900] | |
141_LEU | PRO |
ClinVar chr22:30038249 |
rs2146894322
|
Likely pathogenic | - | not provided [MedGen:C3661900] | |
144_TYR | TER |
ClinVar chr22:30038259 |
rs1060503667
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
147_GLN | TER |
ClinVar chr22:30038266 |
rs2146894926
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
161_GLY | TER |
ClinVar chr22:30050679 |
rs1303879665
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
165_GLN | TER |
ClinVar chr22:30050691 |
rs1601611973
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
167_GLU | TER |
ClinVar chr22:30050697 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
168_LEU | TER |
ClinVar chr22:30050701 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
177_TYR | TER |
ClinVar chr22:30051597 |
rs780880330
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
177_TYR | TER |
ClinVar chr22:30051597 |
-
|
Pathogenic | - | Hereditary cancer-predisposing syndrome [MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
182_GLU | TER |
ClinVar chr22:30051610 |
rs74315495
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
184_TRP | TER |
ClinVar chr22:30051617 |
rs1555993293
|
Likely pathogenic | - | Ependymoma [Human Phenotype Ontology:HP:0002888,MONDO:MONDO:0016698,MeSH:D004806,MedGen:C0014474,Orphanet:251636] | |
185_GLU | TER |
ClinVar chr22:30051619 |
rs2146972508
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
192_TYR | TER |
ClinVar chr22:30051642 |
-
|
Pathogenic | - | Hereditary cancer-predisposing syndrome [MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
196_ARG | TER |
ClinVar chr22:30051652 |
rs1555993336
|
Pathogenic | - | Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
198_ARG | TER |
ClinVar chr22:30051658 |
rs1555993345
|
Pathogenic | - | Neurofibromatosis, type 2|not provided [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637|MedGen:C3661900] | |
204_GLU | TER |
ClinVar chr22:30054188 |
-
|
Pathogenic | - | Hereditary cancer-predisposing syndrome [MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
204_GLU | GLN |
8.3kJPN chr22:30054188 |
rs1569295916
|
- | 0.0003 | - | |
212_GLN | TER |
ClinVar chr22:30054212 |
rs2146989887
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
215_GLU | TER |
ClinVar chr22:30054221 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
219_VAL | MET |
ClinVar chr22:30054233 |
rs1555994816
|
Likely pathogenic | - | not provided [MedGen:CN517202] | |
220_ASN | TYR |
ClinVar chr22:30054236 |
rs1601618646
|
Pathogenic | - | Neurofibromatosis, type 2|not provided [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637|MedGen:C3661900] | |
221_TYR | TER |
ClinVar chr22:30054241 |
rs2146990737
|
Pathogenic | - | not provided|Hereditary cancer-predisposing syndrome [MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
227_LYS | TER |
ClinVar chr22:30057197 |
rs2066466759
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
249_ARG | TER |
ClinVar chr22:30057263 |
-
|
Pathogenic | - | Hereditary cancer-predisposing syndrome [MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162] | |
251_THR | ASN |
8.3kJPN chr22:30057270 |
-
|
- | 0.0001 | - | |
252_PRO | ALA |
8.3kJPN chr22:30057272 |
-
|
- | 0.0001 | - | |
258_TRP | TER |
ClinVar chr22:30057292 |
rs2147010427
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
262_ARG | TER |
ClinVar chr22:30057302 |
rs74315496
|
Pathogenic | - | Neurofibromatosis, type 2|not provided [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637|MedGen:C3661900] | |
266_TYR | TER |
ClinVar chr22:30057316 |
rs917257652
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
269_LYS | TER |
ClinVar chr22:30057323 |
-
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
288_SER | TER |
ClinVar chr22:30061031 |
rs2066580454
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
291_ARG | CYS |
8.3kJPN chr22:30061039 |
rs754093587
|
- | 0.0001 | - | |
298_GLN | TER |
ClinVar chr22:30064328 |
rs2147051643
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] | |
312_LYS | TER |
ClinVar chr22:30064370 |
rs2147052253
|
Pathogenic | - | Neurofibromatosis, type 2 [MONDO:MONDO:0007039,MedGen:C0027832,OMIM:101000,Orphanet:637] |